ꢀ
V.T. Perez et al. / Tetrahedron 70 (2014) 8614e8618
8617
4.2. Procedure I for boramide 2 preparation
(50 MHz DMSO-d6): 48.2 (CH2), 49.2 (CH2), 118.3 (2C), 118.4 (CH),
118.7 (CH), 118.9 (CH), 119.3 (CH), 128.1 (CH), 129.1 (CH), 129.3 (CH),
154.7 (2C), 155.0 (C) ppm; Mþe(HO)2BOMe, found 264.0782.
A solution of the imine 1 (100 mg, 0.3 mmol) in THF:MeOH 5:1
(6 mL) was treated under argon atmosphere with NaBH4 (36 mg,
0.8 mol). After 30 min under agitation, the reaction mixture was
poured over water and the resulting colourless crystals of the
boramide 2 (73.2 mg, 0.27 mmol, 91% yield) were filtered under
suction.
C14H15NO2Cl requires 264.0786.
4.3.5. 12H,14H-[1,3,2]benzoxazaborinino[2,3-b][1,3,2](4-
bromobenzo)oxaza-borinineꢂMeOH (6). Prepared from imine 11
(1.50 mmol), 5-bromosalicylaldehyde (302 mg; 1.50 mmol) and
NaBH4 (65 mg, 1.73 mmol) in 45% yield (235 mg, 0.70 mmol). Mp
177e178 ꢀC (CH2Cl2/MeOH). nmax (Nujol) 1133, 1455, 1499,
4.3. Procedure II for boramides 2e6 preparation
3162 cmꢁ1
; dH (200 MHz MeOD): 3.35 (3H, s), 3.99 (2H, d, J
Imines 7e11 were prepared by treatment of a solution of the
corresponding salicylaldehyde (1.00 mmol) in a 1:1 mixture of
MeOH:THF (1.0 mL) with NH3 gas during 1 min. The reaction
mixture was then used for the preparation of the boramides
without isolating the intermediate imines.
NaBH4 (1.15 mmol) and the corresponding salicylaldehyde
(1.00 mmol) were added in small amounts to the solution of the
corresponding imine (7e11) (1.00 mmol) at room temperature.
After 30 min under agitation, the reaction mixture was poured over
iced water and the resulting crystals (colourless or light yellow) of
the boramide were filtered under suction.
14.6 Hz), 4.24 (2H, d, J 14.6 Hz), 6.65e6.85 (3H, m), 7.02e7.23 (4H,
m) ppm; dC (50 MHz DMSO-d6): 48.2 (CH2), 49.3 (CH2),
115.9 (CH), 118.4 (C), 118.7 (CH), 119.3 (CH), 128.1 (CH), 128.7 (CH),
129.3 (CH), 129.7 (CH), 154.7 (C), 155.0 (C), 157.4 (2C) ppm;
Mþe(HO)2BOMe, found 308.0284. C14H15NO2Br requires
308.0281.
Acknowledgements
ꢀ
Financial support for this work from the Junta de Castilla y Leon
(SA223A11-2) and the University of Salamanca is gratefully ac-
knowledged. We thank to Mass Spectrometry Service and X-ray
Diffraction Service of the NUCLEUS Platform of the University of
Salamanca. We also thank the Ministry of Education of Spain for the
grant to A.L.F.A. (Grant: AP-2009-3338), the University of Sala-
4.3.1. 12H,14H-[1,3,2]benzoxazaborinino[2,3-b][1,3,2]benzoxaza-bor-
inineꢂMeOH (2). Prepared from imine 7 (1.65 mmol), salicylalde-
hyde (200 mg; 1.65 mmol) and NaBH4 (72 mg, 1.90 mmol) in 97%
yield (429 mg, 1.60 mmol). Mp 210e215 ꢀC (CH2Cl2/EtOH). nmax
ꢀ
manca for the grant to O.H.R. (Grant: 70894403P), Dr. Cesar Raposo
(Nujol) 1586, 1612, 3169, 3637 cmꢁ1
; dH (200 MHz DMSO-d6): 3.31
ꢀ
for the mass spectra and useful advice and Dr. Victoria Alcazar for
(3H, s), 3.92 (2H, d, J 14 Hz), 4.21 (2H, dd, J 10, 14 Hz), 6.70 (2H, d, J
8 Hz), 6.75 (2H, t, J 8 Hz), 6.96e7.16 (4H, m), 7.60 (1H, br s) ppm; dC
(50 MHz DMSO-d6): 47.3 (CH2), 48.0 (CH2), 117.7 (C), 118.0 (2CH),
118.2 (C), 127.2 (CH), 127.4 (2CH), 128.1 (CH), 128.4 (2CH), 154.3 (2C)
ppm; HRMS (ESI-QTOF) MþeMeOH, found 238.1031. C14H13BNO2
requires 238.1034.
her kind help.
Supplementary data
1H and 13C NMR, IR and HRMS spectra of compounds 2e6, X-ray
diffraction data of compound 2 and Cartesian coordinates of the
optimized structures are included. Crystallographic data (excluding
structure factors) for the structure in this paper have been de-
posited within the Cambridge Crystallographic Data Centre as
supplementary publication. Copies of the data can be obtained, free
of charge, on application to CCDC, 12 Union Road, Cambridge
CB2 1EZ, UK, (fax: þ44-(0)1223-336033 or e-mail: depos-
4.3.2. 12H,14H-[1,3,2](4-chlorobenzo)oxazaborinino[2,3-b][1,3,2](4-
chlorobenzo)oxazaborinineꢂMeOH (3). Prepared from imine
8
(1.50 mmol), 5-chlorosalicylaldehyde (235 mg; 1.50 mmol) and
NaBH4 (65 mg, 1.73 mmol) in 70% yield (360 mg, 1.05 mmol). Mp
157e161 ꢀC (CH2Cl2/MeOH). nmax (Nujol) 1125, 1488, 3149 cmꢁ1
; dH
(200 MHz MeOD): 3.35 (3H, s), 3.93 (2H, d, J 15.3 Hz), 4.23 (2H, d, J
15.3 Hz), 6.79 (2H, d, J 8.8 Hz), 7.07 (2H, s), 7.13 (2H, d, J 8.8 Hz) ppm;
dC (50 MHz DMSO-d6): 47.6 (2CH2), 120.3 (2CH), 120.4 (2CH), 121.6
(C), 122.4 (2C), 122.9 (C), 127.3 (CH), 128.6 (CH), 153.5 (C), 153.9 (C)
ppm; HRMS (ESI-QTOF) Mþe(HO)2BOMe, found 298.0404.
References and notes
C
14H14NO2Cl2 requires 298.0396.
4.3.3. 12H,14H-[1,3,2](4-bromobenzo)oxazaborinino[2,3-b][1,3,2](4-
bromobenzo)oxazaborinineꢂMeOH (4). Prepared from imine
9
3. Stern, D. R.; Weck, F. J. U.S. Patent Appl. 3 266 981, 1966.
4. Weintraub, M. H.; Melotik D. J.; Anderson, A. E. EP 105740 B1, 1987.
(1.50 mmol), 5-bromosalicylaldehyde (302 mg; 1.50 mmol) and
NaBH4 (65 mg, 1.73 mmol) in 85% yield (545 mg, 1.30 mmol). Mp
194e198 ꢀC (CH2Cl2/MeOH). nmax (Nujol) 1133, 1480, 3155 cmꢁ1
; dH
ꢀ
ꢀ
ꢀ
ꢀ
(200 MHz MeOD): 3.31 (3H, s), 3.93 (2H, d, J 15.3 Hz), 4.23 (2H, d, J
15.3 Hz), 6.74 (2H, d, J 8.4 Hz), 7.21 (2H, s), 7.27 (2H, d, J 8.4 Hz) ppm;
dC (50 MHz DMSO-d6): 47.4 (2CH2), 109.9 (2C), 110.4 (C), 120.9
(4CH), 130.6 (CH), 131.8 (CH), 153.9 (C), 154.3 (C) ppm; HRMS (ESI-
QTOF) Mþe(HO)2BOMe, found 385.9394. C14H14NO2Br2 requires
385.9386.
ꢀ
4.3.4. 12H,14H-[1,3,2]benzoxazaborinino[2,3-b][1,3,2](4-
chlorobenzo)oxazaborinineꢂMeOH (5). Prepared from imine 10
(1.50 mmol), 5-chlorosalicylaldehyde (235 mg; 1.50 mmol) and
NaBH4 (65 mg, 1.73 mmol) in 50% yield (230 mg, 0.75 mmol). Mp
176e180 ꢀC (CH2Cl2/MeOH). nmax (Nujol) 1115, 1452, 1488,
€
3149 cmꢁ1
;
dH (200 MHz MeOD): 3.36 (3H, s), 3.97 (2H, d, J 13.2 Hz),
4.23 (2H, d, J 13.2 Hz), 6.70e6.85 (3H, m), 7.03e7.10 (4H, m) ppm; dC